Actinium Pharmaceuticals, Inc.

ATNM·NYSE American·Healthcare
Compare
1.4100+0.0100 (+0.71%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.4000
Open1.4200
Day range1.36011.4400
52-week range0.73501.7200
Off day high−2.08%
Off 52-week high−18.02%
Volume104.26K
Avg. volume (3M)187.23K
Market cap44.33M
EPS (TTM)0.3600
Forward P/E-2.69
P/E ratio (TTM)3.92
Dividend yield—
Beta (5Y)0.26
Shares outstanding31.44M
Short interest2.02% of float
Earnings dateAug 4, 2025 (est.)
Analyst target4.0000
Profit margin32.23%

Against its peers

Compare in full ›
ATNM ATORX.ST CLRB HBP.TO PYXS SCLP.L
Market cap 44.33M 38.54M 11.63M 70.27M 198.30M 116.66M
P/E (TTM) 3.9 — — — — —
Forward P/E -2.7 -0.1 -0.6 -8.4 -1.5 -370.6
Price/book 1.5 0.3 0.3 4.8 9.2 -4.6
Dividend yield — — — — — —
1-year change +4.48% −99.44% −64.14% −54.68% −58.91% −13.71%
Today +0.71% +0.93% −6.11% 0.00% +1.22% +1.16%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All ATNM news ›
MarketScreener··2 outletsPositive

Actinium Pharmaceuticals, Inc. Unveils Atnm-400 Data At Eanm 2026 with First-In-Human Her3-Targeted Radiotherapy Approach Beyond Psma in Prostate Cancer

Actinium Pharmaceuticals, Inc. announced encouraging initial clinical results from the first-in-human Phase 1 study of ATNM-400 in metastatic castration-resistant prostate cancer . The findings,... announced encouraging initial clinical…

More from 1 other outlet

From the 4Search news index, newest first.

In the news

23mentions in 30 days
21with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 23 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance